Immune privilege in the retina

Ocular Immunology and Inflammation

Volumn 6, Issue 4, 1998, Pages 257-267

  Gregerson, Dale S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ACAID; Autoimmunity; Immune tolerance; Immunoregulation; Sequestration

Indexed keywords

AUTOIMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; RETINA; REVIEW;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; RETINA;

EID: 0032434939     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.6.4.257.4029     Document Type: Review

References (68)

1. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol 1997;158:3557-3560.
2. Streilein JW, Takeuchi M, Taylor AW. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum Immunol 1997;52:138-143.
3. Jiang LQ, Jorquera M, Streilein JW. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci 1993;34:3347-3354.
4. Wenkel H, Streilein JW. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Vis Sci 1998;39:1823-1834.
5. Hara Y, Caspi RR, Wiggert B, Chan CC, Wilbanks GA, Streilein JW. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J Immunol 1992;148:1685-1692.
6. Yamada S, DePasquale M, Patlak SC, Cserr HF. Albumin outflow into deep cervical lymph from different regions of rabbit brain. Am J Physiol 1991;261:H1197-H1204.
7. Harling-Berg CJ, Knopf PM, Cserr HF. Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol 1991;35:45-51.
8. Cserr HF, Knopf PM. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 1992;13:507-512.
9. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991;32:2201-2211.
10. Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol 1994;153:1080-1086.
11. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992;11:1199-1206.
12. Ferguson TA, Fletcher S, Herndon J, Griffith TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol 1995;155:1746-1756.
13. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol 1994;153:1982-1989.
14. Holtkamp GM, Van Rossem M, de Vos AF, Willekens B, Peek R, Kijlstra A. Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol 1998;112:34-43.
15. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994;84:1201-1208.
16. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-3813.
17. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege [see comments]. Science 1995;270:1189-1192.
18. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997;99:396-402.
19. Yamagami S, Kawashima H, Tsuru T, Yamagami H, Kayagaki N, Yagita H, Okumura K, Gregerson DS. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997;64:1107-1111.
20. Kawashima H, Yamagami S, Tsuru T, Gregerson DS. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation. Eur J Immunol 1997;27:2490-2494.
21. Griffith TS, Yu XH, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996;5:7-16.
22. Sabelko KA, Kelly KA, Nahm MH, Cross AH, Russell JH. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol 1997;159:3096-3099.
23. Waldner H, Sobel RA, Howard E, Kuchroo VK. Fas-and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997;159:3100-3103.
24. Wilbanks GA, Mammolenti M. Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol 1992;22:165-173.
25. Ferguson TA. The molecular basis of anterior chamber associated immune deviation (ACAID). Ocular Immunol Inflam 1997;5:213-215.
26. Streilein JW. Molecular basis of ACAID. Ocular Immunol Inflam 1997;5:217-218.
27. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72:551-560.
28. Martin WD, Egan RM, Stevens JL, Woodward JG. Lens-specific expression of a major histocompatibility complex class I molecule disrupts normal lens development and induces cataracts in transgenic mice. Invest Ophthalmol Vis Sci 1995;36:1144-1154.
29. Forrester JV, McMenamin PG, Holthouse I, Lumsden L, Liversidge J. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye - implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1994;35:64-77.
30. Zhang J, Wu GS, Ishimoto S, Pararajasegaram G, Rao NA. Expression of major histocompatibility complex molecules in rodent retina -immunohistochemical study. Invest Ophthalmol Vis Sci 1997;38:1848-1857.
31. Yang PZ, Devos AF, Kijlstra A. Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Invest Ophthalmol Vis Sci 1996;37:77-85.
32. 3-induced experimental autoimmune uveitis. J Immunol 1989;142:1512-1517.
33. Fujinami R, Oldstone M. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985;230:1043-1045.
34. Hickey W, Hsu B, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254-260.
35. Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK, Lutty GA, McLeod DS. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1998;39:754-762.
36. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J Immunol 1996;157:2262-2271.
37. Broekhuyse RM, Kuhlmann ED. Assay of S-antigen immunoreactivity in mammalian retinas in relation to age, ocular dimension and retinal degeneration. Jpn J Ophthalmol 1989;33:243-250.
38. De Kozak Y, Sakai J, Thillaye B, Faure JP. S antigen-induced experimental autoimmune uveo-retinitis in rats. Curr Eye Res 1981;1:327-337.
39. Faure JP, De Kozak Y, Dorey C, Tuyen VV. [Activity of different antigenic preparations from the retina to induce experimental auto-immune uveo-retinitis (EAU) in guinea pigs (author's transl)]. Arch Ophtalmol 1977;37:47-60.
40. Fling SP, Donoso LA, Gregerson DS. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen. J Immunol 1991;147:483-489.
41. Fox GM, Redmond TM, Wiggert B. Kuwabara T, Chader GJ, Gery I. Dissociation between lymphocyte activation for proliferation and for the capacity to adoptively transfer uveoretinitis. J Immunol 1987;138:3242-3246.
42. Mannie MD, Rosser JM, White GA. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. J Immunol 1995;154:2642-2654.
43. Happ MP, Heber-Katz E. Differences in the repertoire of the Lewis rat T cell response to self and non-self myelin basic proteins. J Exp Med 1988;167:502-513.
44. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-766.
45. Gregerson DS, Fling SP, Donoso LA, Gold DP. Unresponsiveness to self-peptides of S-antigen in EAU: an overview of recent results. Curr Eye Res 1992;11:67-74.
46. Merryman CF, Donoso LA, Zhang XM, Heber-Katz E, Gregerson DS. Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes. J Immunol 1991;146:75-80.
47. Gregerson DS, Merryman CF, Obritsch WF, Donoso LA. Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in Lewis rats. Cell Immunol 1990;128:209-219.
48. Gregerson DS, Fling SP, Obritsch WF, Merryman CF, Donoso LA. Identification of T cell recognition sites in S-antigen: dissociation of proliferative and pathogenic sites. Cell Immunol 1989;123:427.
49. De Smet MD, Bitar G, Roberge FG, Gery I, Nussenblatt RB. Human S-antigen: presence of multiple immunogenic and immunopathogenic sites in the Lewis rat. J Autoimmun 1993;6:587-599.
50. Lipham W, Redmond T, Takahashi H, Berzofsky J, Wiggert B, Chader G, Gery I. Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. J Immunol 1991;146:3757-3762.
51. Merryman CF, Smith N, Donoso LA. Identification of multiple associative and dissociative proliferative and uveitogenic T-cell sites in human interstitial retinoid-binding protein. Curr Eye Res 1990;9:97-102.
52. Sanui H, Redmond TM, Kotake S, Wiggert B, Tanaka T, Chader GJ, Gery I. Uveitis and immune responses in primates immunized with IRBP-derived synthetic peptides. Curr Eye Res 1990;9:193-199.
53. Sanui H, Redmond T, Kotake S, Wiggert B, Hu LH, Margalit H, Berzofsky J, Chader G, Gery I. Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J Exp Med 1989;169:1947-1960.
54. Faure JP, Mirshahi M. S-antigen in non ocular tissues. Curr Eye Res 1990;9:163-167.
55. Jeansonne NE, Jazwinski SM, Donoso LA. A 48-kDa, S-antigen-like phosphoprotein in yeast DNA-replicative complex preparations. J Biol Chem 1991;266:14675-14680.
56. Dua HS, Reyes PF, Barrett JA, Abrams MS, Schwarting R, Craft CM, Donoso LA. Identification of an S-antigen-like molecule in human choroid plexus and cerebrospinal fluid. Eye 1992;6:594-598.
57. Sterne-Marr R, Gurevich VV, Goldsmith P, Bodine RC, Sanders C, Donoso LA, Benovic JL. Polypeptide variants of beta-arrestin and arrestin3. J Biol Chem 1993;268:15640-15648.
58. McPherson SW, Gregerson DS. Nucleotide sequences homologous to retinal S-antigen in the rat thymus lack a known EAU inducing epitope. In: Nussenblatt RB, Whitcup SM, Caspi RR, Gery I, editors. Sixth International Symposium on the Immunology and Immunopathology of the Eye. Bethesda, MD, USA: Elsevier Sciences B.V., 1994; 67-70.
59. Donoso LA, Merryman CF, Sery TW, Shinohara T, Dietzschold B, Smith A, Kalsow CM. S-antigen: characterization of a pathogenic epitope which mediates experimental autoimmune uveitis and pinealitis in Lewis rats. Curr Eye Res 1987;6:1151-1159.
60. Craft CM, Whitmore DH. The arrestin superfamily: cone arrestins are a fourth family. FEBS Lett 1995;362:247-255.
61. Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 1997;159:3109-3112.
62. Mathisen PM, Pease S, Garvey J, Hood L, Readhead C. Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci USA 1993;90:10125-10129.
63. Jolicoeur C, Hanahan D, Smith KM. T cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 1994;91:6707-6711.
64. MacKenzie-Graham AJ, Pribyl TM, Kim S, Porter VR, Campagnoni AT, Voskuhl RR. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis. J Immunol 1997;159:4602-4610.
65. Farr AG, Rudensky A. Medullary thymic epithelium: a mosaic of epithelial 'self'? J Exp Med 1998;188:1-4.
66. Adelstein S, Pritchard-Briscoe H, Anderson TA, Crosbie J, Gammon G, Loblay RH, Basten A, Goodnow CC. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science 1991;251:1223-1225.
67. Mickey W, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292.
68. Nossal GJV. Negative selection of lymphocytes. Cell 1994;76:229-239.